Most dream to live, I live my dream
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Some people just can't help themselves and he is obviously one of them. Same pattern forever. Will never change. But IMO MONI will. Hope you're enjoying your life. Some never will.
Cheers
Much to cheer about
I AM certain of what's to come here
Again, Jeff's best work yet by far, very far
Buckle up
Dubai in 3 weeks? Hmmm MMA
MRES
I AM, .20+ and that's conservative
What few fail to realize is current reality. New ticket, years in the making. The time is now. The amount of things that are about to come to fruition ate staggering.
Jeff himself has 40+ years of success under that hoodie! And this will be his best work ever. His business legacy. Look into his track record which is why he wears hoodies 🤣
I've been at this for a long time. I've never met a CEO like Jeff Robinson and I never again will or need to.
What I'm holding, and I'm holding, I'm set for life. So grateful, humbled, honored.
To each their own
MRES
Keys to the kingdom for those who bought tickets
Blessings
MONI
Is this ever going to happen?
COUV
https://twitter.com/hashtag/health?src=hashtag_click
Calling .03 break today
MRES
Another super productive day at the Hout Bay offices of $MRES visiting the #M2Enviro team - Incredible to think these brilliant scientists have come up with a 100% biodegradable substrate for packaging and as a fire retardant using only 2 ingredients: #Hemp and #Mycelium - pic.twitter.com/FgQ5oXhQea
— M2Bio Sciences: $MRES & $RLAB (@m2bio) July 11, 2023
Once in a lifetime opportunity
Check Jeff's previous accomplishments
This will be his best work ever
Buckle up
MRES
This is Jeff's grand finale
What he's accomplished prior to this is amazing. Yet this is by far his best work yet.
I think most people still have no idea of the magnitude of what is to come. Yet, the world is about to
So grateful to be a share holder for this life changing event
MRES
$MRES - #NFTs and #Altcoins for #drugdiscovery using the #Blockchain? WTF is he talking about?🤔 I'm going to put together a few vids to help everybody understand the massive oportunity in the democratization of drug discovery. The impact and implications are mind boggling. Stay… pic.twitter.com/Fwdo5SxEWT
— Jeff Robinson, CEO and Chairman of $MRES and $RLAB (@contrariansmind) June 29, 2023
I think the gringo gap filled
Lmao
MONI
Completely agree
Like good over evil
Doesn't stand a chance
MONI
Back in #Dubai, just so much going on here in technology and medicine. 🩺 Lots of seriously advanced work going on with $MRES and #blockchaintechnology, #cryptocurrency, and #NFT for drug discovery, transparency, and democratization of investments into such. Pr coming? 😉#stocks pic.twitter.com/bTemcJobvs
— M2Bio Sciences: $MRES & $RLAB (@m2bio) June 21, 2023
#HappyYouthDay South Africa🤗Looking forward to another spectacular day. Great to see some new shareholders joining the M2Bio journey.🙏 PR today. Go $MRES #drugdiscovery #artificialintelligence #machinelearning #ScienceInAction #medicine #health #stocks #investing 🚀📈 pic.twitter.com/vGCNgGlUbl
— M2Bio Sciences: $MRES & $RLAB (@m2bio) June 16, 2023
Credibility aligns with credibility
MONI
CAPE TOWN, SOUTH AFRICA -- June 14, 2023 -- InvestorsHub NewsWire -- Institute of Biomedical Research Corp. (OTC PINK: MRES) ("Institute of Biomedical Research" or the "Company"), a nutraceutical biotechnology company focused on alternative plant-based cannabinoids, medical psilocybin and mental health therapeutic research powered by artificial intelligence, and evidence-based sustainable products and solutions, is pleased to share the following update:
The sustainability division of M2Bio Sciences, M2Enviro, is delighted to announce its ongoing commitment to pushing the boundaries of sustainable packaging with the development of its ground-breaking product, Hempcelium™. This biodegradable and eco-friendly packaging solution, made from hemp and mycelium, has gained significant public interest throughout the R&D process due to its positive environmental impact and the growing demand for sustainable alternatives to single-use plastics. Furthermore, M2Enviro is looking to open more R&D pipelines to explore different classes of mycelium composite materials and their applications.
The packaging industry is facing a critical need for sustainable solutions in response to the rising demand for environmentally friendly packaging and growing consumer awareness of the detrimental effects of single-use plastics. Despite this demand, the industry still heavily relies on non-biodegradable materials. It is imperative to find innovative and eco-conscious alternatives that can meet the changing requirements of businesses and consumers. M2Enviro acknowledges this urgent challenge and is committed to greatly expanding its research and development initiatives to explore novel types of mycelium composite materials for the development of sustainable packaging solutions.
One such example of a new R&D pipeline is that of heat-pressed mycelium composite materials. Subjecting mycelium composite materials to heat and pressure increases the density of the material and changes the orientation of the fibers in the material into the same plane. The resulting material generally exhibits significantly higher mechanical strength and durability than non-heat-pressed mycelium composite materials that are just dehydrated. Applications for such a material range from furniture, interior design applications, or building materials.
"We are very proud of Aidan and the M2Enviro team. In such a short period, they have engineered a smart composite material that is ready for prime time. The addressable market is massive, and we look forward to capturing our fair share. Out with plastics and in with Hempcelium™" - said Jeff Robinson, Institute of Biomedical Research CEO.
Aidan Price, Managing Director of M2Enviro, emphasizes the importance of M2Enviro's mission, stating, "Our goal at M2Enviro is to revolutionize the packaging and material industry by providing innovative solutions that address the environmental challenges we face today. Hempcelium™ is just the beginning of our journey. We believe that by exploring different classes of mycelium composite materials, we can unlock new opportunities and applications that will further contribute to a greener future."
In addition, M2Enviro is pleased to announce it will be launching a Pilot Project to test the capabilities of Hemp in soil remediation. Soil remediation is the process of restoring contaminated or degraded soil to a healthier and more productive state. Hemp can absorb and accumulate high levels of heavy metals, pesticides, solvents, and other pollutants from the soil. The roots of hemp plants can reach deep into the soil, secreting enzymes that aid in breaking down and converting contaminants into less toxic forms. Furthermore, hemp is also effective at atmospheric carbon sequestration. It can absorb carbon dioxide from the atmosphere, converting and storing it as organic carbon, to aid in the fight against climate change by offsetting greenhouse gas emissions. This, in combination with its rapid growth rate and ability for high biomass production, makes it a strong candidate for use in biotechnological applications such as biomaterials. M2Enviro is using hemp in our biodegradable and sustainable Hempcelium™ packaging solution, an alternative to petroleum-derived packaging products. M2Enviro's Hempcelium™ is a product engineered for the future and a circular economy.
M2Enviro's commitment to sustainability and its innovative approach to mycelium composite materials are poised to reshape the packaging and material landscape. By continuously pushing the boundaries of research and development, M2Enviro remains at the forefront of creating environmentally friendly alternatives that meet the growing demands of a conscious consumer base.
About Institute of Biomedical Research Corp./ DBA M2Bio Sciences
Institute of Biomedical Research Corp, is a nutraceutical biotechnology company focused on alternative plant-based cannabinoids, medical psilocybin and mental health therapeutic research powered by artificial intelligence, and evidence-based sustainable products and solutions, that develops and commercializes a range of CBD and mushrooms-based products under Dr. AnnaRx™, Medspresso™, Liviana™ brands as well as artificial intelligence powered nutrition products and solutions under the M2Biome brand. In addition, our research and clinical trials with psilocybin are aimed at new therapies that will help patients who suffer from alcohol addiction, mental illness, and cardiovascular diseases. Our mission is to advance botanical-based medicine to the forefront by deploying best-practice science and medicine, clinical research, and emerging technologies such as artificial intelligence. The Company is traded on the Over-the-Counter Bulletin Board of NASDAQ under the trading symbol "MRES".
Publicly traded Company (OTC Pink: MRES)
www.m2bio.co
jeff@m2bio.co
+27 72 333 2148
Find M2Bio™ on social media
Facebook: M2Bio
Instagram: M2bio.Sciences
LinkedIn: M2Bio
Twitter: @M2bio
Forward-Looking Statements
Safe Harbour Statement - In addition to historical information, this press release may contain statements that constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release include the intent, belief, or expectations of the Company and members of its management team with respect to the Company's future business operations and the assumptions upon which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, involve risks and uncertainties and that actual results may differ materially from those contemplated by such forward-looking statements. Factors that could cause these differences to include, but are not limited to, failure to complete anticipated sales under negotiations, lack of revenue growth, client discontinuances, failure to realize improvements in performance, efficiency, and profitability, and adverse developments with respect to litigation or increased litigation costs, the operation or performance of the Company's business units or the market price of its common stock. Additional factors that could cause actual results to differ materially from those contemplated within this press release can also be found on the Company's website. The Company disclaims any responsibility to update any forward-looking statements.
MRES
I think you can kiss the sub-penny goodbye IMO. “To the moon, Alice, to the moon!” 🚀📈 $MRES https://t.co/Lj8kmHgkmP
— Jeff Robinson, CEO and Chairman of $MRES and $RLAB (@contrariansmind) June 14, 2023
Looking forward to another great day! 🔊PR is right around the corner. Our M2Enviro division seriously rocks! #sustainability #packaging #hemp #Hempcelium #M2Enviro #sustainableliving#ecofriendly #zerowaste #pennystock $MRES #stockmarket #investing #BreakoutStock 🚀📈 pic.twitter.com/US4SnMUFJf
— M2Bio Sciences: $MRES & $RLAB (@m2bio) June 14, 2023
Maybe much sooner
MONI
Yup
The trend is not your friend
Man what a war this machine has created here!
Mama maria
MONI
This is really getting fun!!!
You've been warned lmao
MONI
Thank you
I always say consider the source
I consider you a credible source
You've been spot on all along and I believe you are still
Very much looking forward to the big reveal and happenings from now till then
Few live in the present moment
It is all that exists. Their is no past or future, only present moment
Blessings
MONI
Huge
Be sure to read each word
Especially what the CEO Jeff Robinson says, each word
Lots of dots to connect there
MRES
Patience prevails once again
Here and elsewhere
Just because things are taking time doesn't mean they aren't happening
This another will fly ; )
BRLL
Literally
Godspeed
MONI
I know a lot of people in OTC land say a lot of things
To da moon. Biggest ever. Zip code changer. Etc.
And, I really do believe this one has huge potential. For many reasons.
We are about to find out. I wish everyone well here.
MONI
Deal getting exponentially larger
Valuation exponentially larger
Yup ridiculous LMAO
Patience pays
MONI
Same
Joined ya
222 equals money in numerology
Ten bagger plus from here
MONI
Biggly
MONI
Patience always rewarded especially when warnings not heeded
MONI
Imagine that!!!!
You've been warned!!!
FOUR!!!!
MONI
Tip of the iceberg
Been being built in baby steps for years now
Giant leaps about to happen
MRES
Boom time
It's flying!!!!
SONN
Yup looks like moni to me , whoops money
SONN
Taking off like a private jet! ; )
SONN
Lovely
SONN
CAPE TOWN, WESTERN CAPE, SOUTH AFRICA, May 25, 2023/EINPresswire.com/ -- Institute of Biomedical Research (OTC PINK: MRES) ("M2Bio Sciences'' or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and mental health therapeutic research is pleased to share the following update:
M2Biome, a division of M2Bio Sciences, is pleased to announce the launch of its website. The website has been set up to serve healthcare professionals and health consumers alike. Sections include a health blog, called ‘Digestible Facts’, educational resources, recipes, and more.
One key feature of the website includes a diabetes screening tool on the home page, which will notify people of their risk of having undiagnosed type 2 diabetes (T2DM) and prompt them to undergo further tests. This is also a valuable tool for highlighting the lifestyle changes that are needed to reduce the risk of developing T2DM and other non-communicable diseases that have similar underlying pathophysiology. Part of the M2Biome mission is to provide education on health and nutrition, and creating awareness of the risk of disease.
“The prevalence of undiagnosed diabetes in South Africa is estimated to be in the region of 45%. Unfortunately, many people are only diagnosed once they have developed complications, which has a huge impact on the quality of life and the cost of managing these individuals. As type 2 diabetes is largely preventable and manageable, I am passionate about creating awareness of risk. I am currently working on further validating the African Diabetes Risk Score to make it more generalizable in the South African population.”, says Nicola Royce, Managing Director of M2Biome.
The recipe section will be the ultimate user-friendly guide to very practical and easy-to-prepare healthy dishes. Each recipe will also serve as an opportunity to educate on the nutritional content of the dish. You will also learn how to make use of simple cooking methods to get the most out of the least ingredients. The recipes are divided into breakfast, lunch, dinner, dessert, snacks, condiments, and drinks for easy access to your needs. Icons have been developed to guide you in meeting your special dietary requirements with confidence.
"Food should be fun, functional, and user-friendly. If you cannot make it, you cannot eat it. It is unacceptable for good produce to go to waste because it is too difficult to make the most of it. Never should any ingredient be used or abused to end up being unhealthy. Cooking should be easy and done in such a way that the end result is multi-beneficial.", says Wilna Eksteen, Cardiometabolic Product Developer.
M2Biome is also developing a Registered Dietitian database for health consumers to seek individualized treatment. While there are some basic principles when it comes to nutrition, there is no ‘blanket’ approach when applying medical nutrition therapy for various conditions. It is important for people to consult a Registered Dietitian to receive an individualized and tailored approach that takes religious requirements, life cycle stage, and dietary requirements and preferences into account.
‘’In line with an individualized approach, M2Biome will be incorporating Artificial Intelligence and Machine Learning for better patient outcomes. Machine learning takes large amounts of data to uncover patterns and insights related to dietary choices, health outcomes, and nutritional needs. Leveraging machine learning algorithms assists with developing personalised nutrition recommendations based on individual factors such as age, gender, activity level, and health conditions, leading to more tailored and effective dietary interventions. This will all be incorporated into an interactive model that assists individuals with ‘health nudges’ by generating meal plans, recipes to go with these meal plans, and even recommendations of where and what to eat, based on their requirements. Individuals can insert their daily activities, which will be documented and made available to their healthcare practitioners. Any health developments are recorded, which assists with adjusting recommendations and advising on any drug and nutrient interactions that should be remedied. This is all really the tip of the iceberg, and the sky appears to be the limit with all of the ‘smart’ technology we have in our lives today and how they can be used to connect the dots to help us lead healthier lives. This new interactive platform is going to be epic!’’ says Jeff Robinson, M2Bio Sciences CEO.
About Institute of Biomedical Research Corp./ DBA M2Bio Sciences
Institute of Biomedical Research Corp, is a nutraceutical biotechnology company focused on alternative plant-based cannabinoids and psilocybin medical research that develops and commercializes a range of CBD and mushrooms-based products under Dr. AnnaRx™, Medspresso™, and Liviana™ brands. In addition, our research and clinical trials with psilocybin are aimed at new therapies that will help patients who suffer from alcohol addiction, mental illness, and cardiovascular diseases. Our mission is to advance botanical-based medicine to the forefront by deploying best-practice science and medicine, clinical research, and emerging technologies. The Company is traded on the Over-the-Counter Bulletin Board of NASDAQ under the trading symbol "MRES".
Publicly traded company (OTC Pink: MRES)
Website: www.m2biome.com
E-mail: m2biome@m2bio.co
Forward-Looking Statements:
Safe Harbour Statement - In addition to historical information, this press release may contain statements that constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release include the intent, belief, or expectations of the Company and members of its management team with respect to the Company's future business operations and the assumptions upon which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Factors that could cause these differences include, but are not limited to, failure to complete anticipated sales under negotiations, lack of revenue growth, client discontinuances, failure to realize improvements in performance, efficiency, and profitability, and adverse developments with respect to litigation or increased litigation costs, the operation or performance of the Company's business units or the market price of its common stock. Additional factors that could cause actual results to differ materially from those contemplated within this press release can also be found on the Company's website. The Company disclaims any responsibility to update any forward-looking statements.
MRES
Everything coming together BRO
GVSI